Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2000
12/20/2000EP1059935A1 Mucosal microparticle conjugate vaccine
12/20/2000EP1059934A2 Matrix protein compositions for wound healing
12/20/2000EP1059932A1 Method for reducing susceptibility to hiv infection
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059928A1 Inorganic nitrite and organic acid in combination as topical antiviral composition
12/20/2000EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide
12/20/2000EP1059911A1 Formulations with an anti-viral effect
12/20/2000EP1059845A1 Fungicide composition comprising a benzoylphenylurea
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0778733B1 A basic protein composition for killing or inhibiting microbial cells
12/20/2000CN1277556A Application of TNF antagonists as medicaments for treating septic diseases
12/20/2000CN1277552A Nitric oxide inhibits rhinovirus infection
12/20/2000CN1277053A Compound tree peony injecta
12/20/2000CN1277041A Sugar-less Radix Isatidis preparation
12/20/2000CN1277026A Pain-relieving, bleeding-stopping and itching-stopping antibacterial medicine
12/20/2000CN1277020A Application of Eight precious extract in preparing antiviral medicine
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/20/2000CN1059576C Traditional Chinese medicine spray and ointment gauze for treatment of wound
12/20/2000CN1059567C Chinese herb medicine preparation for prevention and treatment of poultry and animal diseases
12/20/2000CN1059561C 'Shengqiaoergan' instant particles with Chinese herb medicines and its preparing method
12/19/2000US6162918 Tetramethylacridinedione derivatives are inhibitors of herpes simplex virus thymidine kinase in the treatment and prophylaxis of infections caused by herpes simplex virus.
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162809 Pyridylthio compounds for controlling helicobacter bacteria
12/19/2000US6162793 Bactericides and antibiotics
12/19/2000US6162792 Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162790 Oligopeptides
12/19/2000US6162788 Chlamydia intracellular inclusion bodies in cells
12/19/2000US6162786 Bactericides that inhibit ovomacroglobulin
12/19/2000US6162631 Retrovirus from the HIV group and its use (MVP-2901/94)
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
12/19/2000US6162440 Variant competes with ebna2 protein for cbf1, a cellular dna-binding protein; ebna2 is a transcriptional activator that regulates viral latency gene expression and activates expression of cellular genes; suppressing epstein-barr virus
12/19/2000US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids
12/19/2000US6162436 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000US6162433 A transformed cell which is an attenuated strain of its natural counterpart, can be engineered to express at least one antigen and at least one safe, selectable marker
12/19/2000US6162429 Biologically pure serpens spp. strain hbl-112 (atcc 202005); treating infectious disease of the feet and/or lower legs of cattle
12/19/2000US6162420 Use of glyceryl triacetate for treating onychomycoses
12/19/2000CA2174658C Novel composition
12/19/2000CA2001225C Antimicrobial lactam-quinolones
12/14/2000WO2000075665A1 Early detection of flaviviruses using the ns1 glycoprotein
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075351A1 Siv-based packaging-defficient vectors
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075336A2 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075181A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000WO2000075180A2 Peptides for vaccinating against human cmv
12/14/2000WO2000075178A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000WO2000075177A1 Echinocandin derivatives, method for preparing same and application as antifungal agents
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075156A1 6-o-carbamate ketolide derivatives
12/14/2000WO2000075143A1 Crystals of carbapenem derivatives and pharmaceutical preparations for injection
12/14/2000WO2000075142A2 Dna methyltransferase inhibitors
12/14/2000WO2000075131A1 Substituted pyrazole compounds
12/14/2000WO2000075122A1 Novel processes for the preparation of substituted propenone derivatives
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074693A2 Immunity generation
12/14/2000WO2000074691A1 Treatment of cutaneous leishmaniasis and other dermatological diseases mainly wounds (diabetic ulcers) by idogenos sanhory
12/14/2000WO2000074686A1 Modulators of methylation for control of bacterial virulence
12/14/2000WO2000074677A2 Improved pharmaceutical formulations
12/14/2000WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000WO2000053775A3 Prevention and treatment of viral infections
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049040A3 Antimicrobial/endotoxin neutralizing polypeptide
12/14/2000WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation
12/14/2000WO2000048615A3 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
12/14/2000WO2000047224A3 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
12/14/2000WO2000045841A3 Human papilloma virus vaccine formulations
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000CA2390090A1 Peptides
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376790A1 Siv-based packaging-defficient vectors
12/14/2000CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376490A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376043A1 Novel processes for the preparation of substituted propenone derivatives
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375627A1 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
1 ... 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 ... 1798